α/β-Peptides as Nanomolar Triggers of Lipid Raft-Mediated Endocytosis through GM1 Ganglioside Recognition
- Supplementary File 1:
ZIP-Document (ZIP, 3979 KiB)
Hetényi, A.; Szabó, E.; Imre, N.; Bhaumik, K.N.; Tököli, A.; Füzesi, T.; Hollandi, R.; Horvath, P.; Czibula, Á.; Monostori, É.; Deli, M.A.; Martinek, T.A. α/β-Peptides as Nanomolar Triggers of Lipid Raft-Mediated Endocytosis through GM1 Ganglioside Recognition. Pharmaceutics 2022, 14, 580. https://doi.org/10.3390/pharmaceutics14030580
Hetényi A, Szabó E, Imre N, Bhaumik KN, Tököli A, Füzesi T, Hollandi R, Horvath P, Czibula Á, Monostori É, Deli MA, Martinek TA. α/β-Peptides as Nanomolar Triggers of Lipid Raft-Mediated Endocytosis through GM1 Ganglioside Recognition. Pharmaceutics. 2022; 14(3):580. https://doi.org/10.3390/pharmaceutics14030580
Chicago/Turabian StyleHetényi, Anasztázia, Enikő Szabó, Norbert Imre, Kaushik Nath Bhaumik, Attila Tököli, Tamás Füzesi, Réka Hollandi, Peter Horvath, Ágnes Czibula, Éva Monostori, Mária A. Deli, and Tamás A. Martinek. 2022. "α/β-Peptides as Nanomolar Triggers of Lipid Raft-Mediated Endocytosis through GM1 Ganglioside Recognition" Pharmaceutics 14, no. 3: 580. https://doi.org/10.3390/pharmaceutics14030580